Nivolumab treatment in melanoma patients has manageable safety profile
The monoclonal antibody nivolumab has shown promise as a therapeutic agent, particularly by improving the survival rates of melanoma patients....
The monoclonal antibody nivolumab has shown promise as a therapeutic agent, particularly by improving the survival rates of melanoma patients....
A portable, finger-probe device successfully measured liver function in brain dead adult organ donors, a finding that could change the...
(A version of this Health Alert was published by Forbes). You might think this headline is a gag, given how...
U.S. News & World ReportJudge Considers House GOP's Case Against Obama's Health LawWall Street JournalHouse Republicans filed a lawsuit in...
Every day we are bombarded by information about diets. Most of that information has some kind of an agenda lurking...
Even as federal regulators take steps to constrain administrative spending by private health insurers, government overhead on health coverage has...
Nearly three-quarters of supermarket chickens are contaminated with a potentially deadly bug, making it the biggest food safety concern in...
(MedPage Today) -- 10 days, 10 questions: Day 8 -- "How should patients with HIV be treated, especially in the...
Prostate cancer is the second most common type of cancer in men and is predicted to result in an estimated...
Scientists are reporting on the first phase 1 study of the JAK2 inhibitor ruxolitinib in CMML patients. SOURCE: Top Health...
Like, you know, turning your bridesmaids into your servants You’re knee-deep in the months of budgeting, working out like a...